- Home
- NKSH vs THRD Comparison
NKSH vs THRD Comparison
Compare NKSH & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- THRD
- Stock Information
- Founded
- NKSH 1891
- THRD 2019
- Country
- NKSH United States
- THRD United States
- Employees
- NKSH N/A
- THRD N/A
- Industry
- NKSH Major Banks
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- NKSH Finance
- THRD Health Care
- Exchange
- NKSH Nasdaq
- THRD Nasdaq
- Market Cap
- NKSH 172.3M
- THRD 157.7M
- IPO Year
- NKSH N/A
- THRD 2022
- Fundamental
- Price
- NKSH $26.01
- THRD $3.36
- Analyst Decision
- NKSH Strong Buy
- THRD Hold
- Analyst Count
- NKSH 1
- THRD 3
- Target Price
- NKSH $38.00
- THRD $5.00
- AVG Volume (30 Days)
- NKSH 8.6K
- THRD 323.1K
- Earning Date
- NKSH 05-14-2025
- THRD 03-27-2025
- Dividend Yield
- NKSH 5.79%
- THRD N/A
- EPS Growth
- NKSH N/A
- THRD N/A
- EPS
- NKSH 1.24
- THRD N/A
- Revenue
- NKSH $44,130,000.00
- THRD N/A
- Revenue This Year
- NKSH $1.17
- THRD N/A
- Revenue Next Year
- NKSH $9.78
- THRD N/A
- P/E Ratio
- NKSH $21.10
- THRD N/A
- Revenue Growth
- NKSH N/A
- THRD N/A
- 52 Week Low
- NKSH $26.00
- THRD $3.18
- 52 Week High
- NKSH $34.15
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- NKSH 36.56
- THRD 32.35
- Support Level
- NKSH $26.76
- THRD $3.34
- Resistance Level
- NKSH $27.90
- THRD $3.68
- Average True Range (ATR)
- NKSH 0.56
- THRD 0.14
- MACD
- NKSH -0.04
- THRD 0.07
- Stochastic Oscillator
- NKSH 0.53
- THRD 5.88
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.